Identification of Metabolic Bone Disease in Patients with Endogenous Hyperthyroidism: Role of Biological Markers of Bone Turnover

Abstract

Active hyperthyroidism is associated with reduced bone mass. Nevertheless, not all patients show the same risk for developing osteoporosis. Our aim was to analyze some clinical and biochemical potential predictors of low bone mass in hyperthyroid patients. We studied 127 consecutive hyperthyroid patients (110 females, 17 males; aged 42 +/- 16 years). Bone mineral density (BMD) was measured by dual X-ray absorptiometry (DXA) at lumbar spine (LS; L2-L4) and femoral neck (FN). Data were expressed as g/cm2 and T-score. Patients were placed into two groups based on recent WHO criteria: Group A, no osteoporosis (n = 98); and group B, lumbar or femoral osteoporosis (n = 29). Study protocol included evaluation of osteoporosis risk factors, anthropometrical variables, thyroid function, and bone turnover markers. Receiver-operating characteristic (ROC) plots for the precision of bone markers and multivariate analysis for the prediction of BMD and osteoporosis were performed. Group B showed greater age and proportion of menopausal females; lower weight, height, and calcium intake; longer duration of menopause; and greater levels of total and bone alkaline phosphatase and of urine hydroxyproline. No differences in thyroid function, osteocalcin, tartrate-resistant acid phosphatase, and type I collagen C-telopeptide (ICTP) were found. The best predictive model accounted for 46% and 62% of the variability of lumbar and femoral BMD respectively and correctly classified 89% of the osteoporotic hyperthyroid patients. No significant difference in ROC plots was observed. It is concluded that hyperthyroid patients with lumbar or femoral osteoporosis show a typical clinical and biochemical profile illustrating that the relationship between BMD and bone markers is better in high turnover states. Classical bone turnover markers show high performance in the evaluation of hyperthyroid bone disease.

Sub-chronic exposure to Kalach 360 SL, Glyphosate-based Herbicide, induced bone rarefaction in female Wistar rats

“…It is a condition where in the thyroid gland is not capable of producing enough thyroid hormone. Since the main purpose of thyroid hormone is to "run the body's metabolism", it is understandable that people with such conditions will have symptoms associated with a slow metabolism (Gimeno et al, 1997;Boas et al, 2006;Patrick, 2009).…”

Osteopenia and decreased bone formation in osteonectin-deficient mice

“…Regarding the data on urinary collagen cross-links, it has been documented that urinary deoxypyridinoline is poorly correlated with bone resorption as assessed by histomorphometry (46). Indeed, the correlation between biochemical parameters of bone remodeling and bone mineral density is greater in high-turnover than in low-turnover states, such as that seen in the osteonectin-null mice (47). Furthermore, for the most part, data on the utility of biochemical parameters as markers of bone remodeling is derived from human studies, and their value in animal models is less well documented.…”

Physiologically based mathematical model of transduction of mechanobiological signals by osteocytes

“…The results of in vitro experiments suggest that fluid shear is a major factor affecting bone cell metabolism (Fox et al 1996;Chow et al 1998;Bakker et al 2003;McGarry et al 2005). Although it is clear that both biological and mechanical factors influence bone adaptation (Vedi and Compston 1996;Jódar Gimeno et al 1997), a review of literature shows that most mathematical proposed stimuli functions are phenomenological and are not developed based on physiological considerations (Prendergast and Taylor 1994;Huiskes et al 2000;Hernandez et al 2001;Hambli et al 2009Hambli et al , 2010. These models assumed that biologic factors remain constant so that only the mechanical aspects of the model were subject to change.…”